There is really no way to overstate the importance of Girolamo Fracastoro's bold proposal about the roots of infection. His idea that infections were caused by "seeds," living things unseen to the naked eye, was followed by deductions that included the spread of contagion, incubation periods, the organs affected by particular infectious agents, the vulnerable age for a particular disease, the idea that a survivor of an infection is protected against future infections, the ability of a disease to pass from mother to child through nursing, and many other valuable observations. His genius, while respected and supported, was not definitively proven until over 100 years later, with the advent of the microscope.
In formal descriptions of the germ-fighting powers of antibacterial and biocidal products, the terms "Gram positive" and "Gram negative" are used as a way to categorize bacteria. While there are estimated to be over 10,000 species of bacteria, they can be categorized into a few helpful categories.
One of those categories has to do with the structure of the cell membrane. All the known bacteria fit into one of two categories of cell membrane structure: Gram-positive or Gram-negative. But what does that mean?
A couple years back, the EOSCU Team had the honor of presenting at the Centers for Disease Control and Prevention (CDC) campus outside of Atlanta, GA. During the meeting with the Division of Healthcare Quality Promotion, we were able to share information about our product as well as data from our first clinical study. This meeting was anything but one-sided, however - the experts at the CDC were able to identify directions and partnerships we should explore in the future. This visit prompted us to present this post about the CDC, and what it does for our nation and the world on a daily basis.
Today is International Women's Day, a day set aside to explore and celebrate the contributions and achievements of women while also bringing visibility to issues of gender disparity that could still use improvement. In today's post, we will look at gender disparities in the medical field, with an emphasis on fields in infection control.
Despite recent controversies about the quality of care in VA hospitals, the network of 163 acute care hospitals and over 1,000 outpatient clinics is actually a national leader when it comes to many treatments and outcomes. Due to incidents of patient harm stemming from, among other issues, prolonged wait times for procedures, the VA instituted a rigorous self-evaluation as well as evaluation from outside experts. The results pointed to changes needed for improvement, but also revealed successes and positive outcomes where the VA exceeds private sector health care. One of those areas is in infection control, and today's post will explore how the VA achieved a leadership role in this area.
The term "white paper" comes to us from a 100-year-old practice of government reportingin the UK. When government agencies provided data to Parliament to help them make decisions, they would offer three different types: Very long, comprehensive documents with a blue cover, open-ended reports with a green cover, and short, focused reports on a single topic with white covers. This last type, the concise document with information to solve a problem, came to be the formula for what is now known in many industries as a "white paper." Today, white papers are produced for sales purposes by for-profit companies, making them a marketing tool that can often be confused with a neutral scientific paper. While both publications have their purpose, it is important for the consumer to know how they differ. Today we will compare these two documents in order to help our readers see beyond the surface similarities and become aware of the important differences.
We at the Health.Care. blog value science and scientists. We trust the scientific method to propose new ideas, and then test, defend, critique, replicate and establish those ideas as quality research. We also recognize the value in stepping back and returning to the literature, reevaluating a premise, and even scrapping a project in order to begin again.
Today we celebrate the birth of a scientist known as the Father of Microbiology for his role in the use of lenses to observe the microscopic world. Optics and lens-making developed quickly in 16-17th century Europe, allowing research to expand to the universe. But just as lenses could sharpen light from far away, allowing Galileo to see Jupiter's moons, it could also magnify objects right in the laboratory. The microscope was invented by several lens makers at around the same time in the late 1500s and the technology spread throughout Europe. In the 1660s, however, the use of microscopes for intense research grew explosively. Discovery after discovery began to lay the groundwork for modern biology.
The US government is one of the largest funders of scientific study in the world. The National Institutes of Science alone funds more medical research than any other source globally. How does the federal government allocate funds to study science? Who decides what goes where? And what role does the President play in this funding? Today we will delve into the complicated process of funding allocations, and how that money funds science.
As we enter the heated month before Election Day, we are going to take an opportunity to explore the relationship between science and our government over the course of a few blog posts. We’ll explore a few key questions: How important was science to the Founding Fathers who penned the documents that still guide us today? How have Presidents interacted with the advancement of science since the birth of our nation? Just how involved is our current government in science, and finally, how do the two major party candidates differ with relation to science? Stay with us over the next few weeks to find out!